A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Telix Pharmaceuticals (Innovations) Pty Limited
Coherence Neuro Australia Pty Limited
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Children's Hospital of Philadelphia
Beijing Tiantan Hospital
National Institutes of Health Clinical Center (CC)
Baptist Health South Florida
UMC Utrecht
The Children's Hospital of Zhejiang University School of Medicine
Pfizer
Baptist Health South Florida
GT Medical Technologies, Inc.
Emory University
Children's Oncology Group
Assistance Publique - Hôpitaux de Paris
Cancer Research UK
Memorial Sloan Kettering Cancer Center
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Stemline Therapeutics, Inc.
Medical University of South Carolina
Iambic Therapeutics, Inc
Uppsala University
Children's Hospital Los Angeles
Australian & New Zealand Children's Haematology/Oncology Group
Mayo Clinic
Swansea Bay University Health Board
University of Maryland, Baltimore
EMD Serono
GlaxoSmithKline
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Reveal Pharmaceuticals Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Odense University Hospital
St. Jude Children's Research Hospital
University Hospital, Lille
Centre Hospitalier Universitaire de Nīmes
Ottawa Hospital Research Institute
Cancer Research UK